MicroRNA-126 Inhibits Osteosarcoma Cells Proliferation by Targeting Sirt1

Overview

Journal Tumour Biol

Publisher Sage Publications

Specialty Oncology

Date 2013 Jul 24

PMID 23877372

Citations 18

Authors

Jian-Qiang Xu

Ping Liu

Ming-Jue Si

Xiao-Yi Ding

Affiliations

Soon will be listed here.

Abstract

Numerous studies have recently suggested that miRNAs contribute to the development of various types of human cancer as well as to their proliferation and metastasis. The aim of this study was to investigate the functional significance of miR-126 and to identify its possible target genes in osteosarcoma (OS) cells. Here, we found that expression level of miR-126 was reduced in osteosarcoma cells in comparison with the adjacent normal tissues. The enforced expression of miR-126 was able to inhibit cell proliferation in U2OS and MG63 cells, while miR-126 antisense oligonucleotides (antisense miR-126) promoted cell proliferation. At the molecular level, our results further revealed that expression of Sirt1, a member of histone deacetylase, was negatively regulated by miR-126. Therefore, the data reported here demonstrate that miR-126 is an important regulator in osteosarcoma, which will contribute to better understanding of the important misregulated miRNAs in osteosarcoma cells.

Citing Articles

miR‑126 overexpression attenuates oxygen‑glucose deprivation/reperfusion injury by inhibiting oxidative stress and inflammatory response via the activation of SIRT1/Nrf2 signaling pathway in human umbilical vein endothelial cells.

Li J, Yang C, Wang Y Mol Med Rep. 2020; 23(2).

PMID: 33355373 PMC: 7789090. DOI: 10.3892/mmr.2020.11804.

Role of Non-Coding RNAs in Lung Circadian Clock Related Diseases.

Chinnapaiyan S, Kumar Dutta R, Devadoss D, Chand H, Rahman I, Unwalla H Int J Mol Sci. 2020; 21(8).

PMID: 32344623 PMC: 7215637. DOI: 10.3390/ijms21083013.

miRNA signatures in childhood sarcomas and their clinical implications.

Viera G, Salomao K, de Sousa G, Baroni M, Delsin L, Pezuk J Clin Transl Oncol. 2019; 21(12):1583-1623.

PMID: 30949930 DOI: 10.1007/s12094-019-02104-z.

Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy.

Heishima K, Meuten T, Yoshida K, Mori T, Thamm D BMC Vet Res. 2019; 15(1):39.

PMID: 30683101 PMC: 6347759. DOI: 10.1186/s12917-019-1776-1.

Therapeutic applications of histone deacetylase inhibitors in sarcoma.

Tang F, Choy E, Tu C, Hornicek F, Duan Z Cancer Treat Rev. 2017; 59:33-45.

PMID: 28732326 PMC: 5581728. DOI: 10.1016/j.ctrv.2017.06.006.

References

Klein M, Siegal G . Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol. 2006; 125(4):555-81. DOI: 10.1309/UC6K-QHLD-9LV2-KENN. View

Li N, Tang A, Huang S, Li Z, Li X, Shen S . MiR-126 suppresses colon cancer cell proliferation and invasion via inhibiting RhoA/ROCK signaling pathway. Mol Cell Biochem. 2013; 380(1-2):107-19. DOI: 10.1007/s11010-013-1664-0. View

Kim J, Chen J, Lou Z . DBC1 is a negative regulator of SIRT1. Nature. 2008; 451(7178):583-6. DOI: 10.1038/nature06500. View

Tan M, Choong P, Dass C . Osteosarcoma: Conventional treatment vs. gene therapy. Cancer Biol Ther. 2008; 8(2):106-17. DOI: 10.4161/cbt.8.2.7385. View

Vaziri H, Dessain S, Ng Eaton E, Imai S, Frye R, Pandita T . hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 2001; 107(2):149-59. DOI: 10.1016/s0092-8674(01)00527-x. View

Esquela-Kerscher A, Slack F . Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6(4):259-69. DOI: 10.1038/nrc1840. View

Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina G . Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene. 2009; 28(46):4065-74. PMC: 2783211. DOI: 10.1038/onc.2009.274. View

Li Y, Backesjo C, Haldosen L, Lindgren U . Resveratrol inhibits proliferation and promotes apoptosis of osteosarcoma cells. Eur J Pharmacol. 2009; 609(1-3):13-8. DOI: 10.1016/j.ejphar.2009.03.004. View

Hua Mao J, Zhou R, Peng A, Liu Z, Huang S, Long X . microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN. Oncol Lett. 2012; 4(5):1125-1129. PMC: 3499598. DOI: 10.3892/ol.2012.863. View

10.

He C, Xiong J, Xu X, Lu W, Liu L, Xiao D . Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples. Biochem Biophys Res Commun. 2009; 388(1):35-40. DOI: 10.1016/j.bbrc.2009.07.101. View

11.

Huffman D, Grizzle W, Bamman M, Kim J, Eltoum I, Elgavish A . SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res. 2007; 67(14):6612-8. DOI: 10.1158/0008-5472.CAN-07-0085. View

12.

Ziyan W, Shuhua Y, Xiufang W, Xiaoyun L . MicroRNA-21 is involved in osteosarcoma cell invasion and migration. Med Oncol. 2010; 28(4):1469-74. DOI: 10.1007/s12032-010-9563-7. View

13.

Motta M, Divecha N, Lemieux M, Kamel C, Chen D, Gu W . Mammalian SIRT1 represses forkhead transcription factors. Cell. 2004; 116(4):551-63. DOI: 10.1016/s0092-8674(04)00126-6. View

14.

Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View

15.

Oka S, Alcendor R, Zhai P, Park J, Shao D, Cho J . PPARα-Sirt1 complex mediates cardiac hypertrophy and failure through suppression of the ERR transcriptional pathway. Cell Metab. 2011; 14(5):598-611. PMC: 3217210. DOI: 10.1016/j.cmet.2011.10.001. View

16.

Jusufovic E, Rijavec M, Keser D, Korosec P, Sodja E, Iljazovic E . let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non--small--cell lung cancer. PLoS One. 2012; 7(9):e45577. PMC: 3454421. DOI: 10.1371/journal.pone.0045577. View

17.

Firestein R, Blander G, Michan S, Oberdoerffer P, Ogino S, Campbell J . The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One. 2008; 3(4):e2020. PMC: 2289879. DOI: 10.1371/journal.pone.0002020. View

18.

Portmann S, Fahrner R, Lechleiter A, Keogh A, Overney S, Laemmle A . Antitumor effect of SIRT1 inhibition in human HCC tumor models in vitro and in vivo. Mol Cancer Ther. 2013; 12(4):499-508. DOI: 10.1158/1535-7163.MCT-12-0700. View

19.

Elangovan S, Ramachandran S, Venkatesan N, Ananth S, Gnana-Prakasam J, Martin P . SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer. Cancer Res. 2011; 71(21):6654-64. PMC: 3206200. DOI: 10.1158/0008-5472.CAN-11-1446. View

20.

Kemper J, Xiao Z, Ponugoti B, Miao J, Fang S, Kanamaluru D . FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab. 2009; 10(5):392-404. PMC: 2785075. DOI: 10.1016/j.cmet.2009.09.009. View